1852 Journal of Medicinal Chemistry, 2009, Vol. 52, No. 7
PerloVich et al.
TG Experiments. Thermogravimetric studies were carried out
within the temperature range 25-200 °C with a heating rate of 10
°C/min and a flow rate of dry argon gas at 5.4 L/h using NETZSCH
TG 209 F1 (Germany). The calibration of the TGA cell was
performed using a sample of calcium oxalate monohydrate in an
atmosphere of flowing dry argon. The measurements were repeated
three times. The determinations were off by 3%.
X-ray Diffraction Experiments. Single-crystal X-ray measure-
ments were carried out using a Nonius CAD-4 diffractometer with
graphite-monochromated Mo KR radiation (λ ) 0.710 69 Å). The
intensity data were collected at 25 °C by means of a ω-2θ scanning
procedure. The crystal structures were solved using direct methods
and refined by means of a full-matrix least-squares procedure.
CAD-4 Software (1989)18 was applied for data collection, data
reduction, and cell refinement. Programs SHELXS-97 and SHELXL-
9719 were used to solve and to refine structures, respectively.
NMR Experiments. NMR data were obtained by standard
methods using Bruker AMX-200.
Biological Methods. Calcium-Blocking Property Experi-
ments. Interaction between the compounds and glutamate-dependent
calcium uptake system was studied on newborn (8-11 days old) rat
brain synaptosomal P2-fraction isolated according to the following
method: synaptosomes were suspended in the incubation buffer A (132
mM NaCl, 5 mM KCl, 5 mM HEPES), pH 7.4, and stored at 0 °C
during all experiments. Aliquots of synaptosomes (50 µL) were
transposed to buffer A containing the testing compound and 45Ca
samples. Calcium ion uptake was stimulated by introducing 200 µM
glutamate solution. After 5 min of incubation at 37 °C, the process
was terminated by filtration on GF/B filters. The sample was washed
three times with cold buffer B (145 mΜ KCl, 10 mΜ Tris, 5 mΜ
Trilon B) followed by measurements of radioactivity with scintillator
counter SL-4000 Intertechnic.
Effects of 1-3 on NMDA receptors were analyzed on a
heterogeneous population of a primary culture of neurons isolated
from rat cerebral cortex.
Acknowledgment. The present research was funded as a part
of the basic research program established by the Presidium of
Russian Academy of Sciences “Fundamental Sciences for Medi-
cine”.
Supporting Information Available: Elemental analysis data,
X-ray data, and NMR spectra of compounds 1-3. This material is
References
(1) Parsons, C. G.; Danysz, W.; Quack, G. Glutamate in CNS disorders
as a target for drug development: an update. Drug News Perspect.
1998, 11, 523–579.
(2) Nakanishi, N. S. Molecular diversity of glutamate receptors and
implications for brain function. Science 1992, 258, 31–37.
(3) Dingledine, R.; Borges, K.; Bowie, D.; Traynelis, S. F. The glutamate
receptor ion channels. Pharmacol. ReV. 1999, 51, 7–61.
(4) Bra¨uner-Osborne, H.; Egebjerg, J.; Nielsen, E. Ø.; Madsen, U.;
Krogsgaard-Larsen, P. Ligands for glutamate receptors: design and
therapeutic prospects. J. Med. Chem. 2000, 43, 2609–2645.
(5) Petrov, V. I.; Piotrovsky, L. B.; Grigoriev, I. A. Exitatory Amino Acids;
Volgograd Medical Academy: Volgograd, Russia, 1997; p 168.
(6) Zefirova, O. N.; Zefirov, N. S. Physiologically active compounds acting
on glutamate receptors. Zh. Org. Khim. 2000, 36, 1273–1300.
(7) Khachaturian, Z. S. Calcium hypothesis of Alzheimer’s disease and
brain aging. Ann. N.Y. Acad. Sci. 1994, 747, 1–11.
(8) Mattson, M. P.; Cheng, B.; Davis, D.; Bryant, K.; Lieberburg, I.; Rydel,
R. E. ꢀ-Amyloid peptides destabilize calcium homeostasis and render
human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 1992,
12, 376–389.
In preliminary experiments, all compounds were tested at 100
µM for their ability to inhibit the glutamate stimulated Ca uptake.
If inhibition of the Glu-Ca-uptake was 50% or more, then further
studies were carried out to determine the concentration dependence
of its inhibition and the corresponding value of KI was measured
according to the following equation:
(9) Bleakman, D.; Lodge, D. Neuropharmacology of AMPA and kainate
receptors. Neuropharmacology 1998, 37, 1187–1204.
(10) Hansch, C.; Bjorkroth, J. P.; Leo, A. Hydrophobicity and central
nervous system agents: on the principle of minimal hydrophobicity
in drug design. J. Pharm. Sci. 1987, 76, 663–686.
(11) Young, R. C.; Mitchell, R. C.; Brown, T. H.; Ganellin, C. R.; Griffiths,
R.; Jones, M.; Rana, K. K.; Saunders, D.; Smith, I. R.; Sore, N. E.;
Wilks, T. J. Development of a new physicochemical model for brain
penetration and its application to the design of centrally acting H2
receptor histamine antagonists. J. Med. Chem. 1988, 31, 656–671.
(12) Abraham, M. H.; Chadha, H. S.; Mitchell, R. C. Hydrogen bonding.
33. Factors that influence the distribution of solutes between blood
and brain. J. Pharm. Sci. 1994, 83, 1257–1268.
(13) Abraham, M. H.; Chadha, H. S.; Mitchell, R. C. Hydrogen bonding.
Part 36. Determination of blood brain distribution using octanol-water
partition coefficients. Drug Des. DiscoVery 1995, 13, 123–131.
(14) Abraham, M. H.; Chadha, H. S. Applications of a Solvation Equation
to Drug Transport Properties. In Lipophilicity in Drug Action and
Toxicology; Pliska, V., Testa, B., van de Waterbeemd, H., Eds.;
Methods and Principles in Medicinal Chemistry, Vol. 4; VCH
Publishers: Weinheim, Germany, 1995.
(15) Bachurin, S. O. Medicinal chemistry approaches for the treatment and
prevention of Alzheimer’s disease. Med. Res. ReV. 2003, 13 (1), 48–88.
(16) Perlovich, G. L.; Hansen, L. K.; Volkova, T. V.; Mirza, S.; Manin,
A. N.; Bauer-Brandl, A. Thermodynamic and structural aspects of
hydrated and unhydrated phases of 4-hydroxy-benzamide. Cryst.
Growth Des. 2007, 7 (12), 2643–2648.
(17) Perlovich, G. L.; Volkova, T. V.; Bauer-Brandl, A. Towards an
understanding of the molecular mechanism of solvation of drug
molecules: a thermodynamic approach by crystal lattice energy,
sublimation and solubility exemplified by hydroxybenzoic acids.
J. Pharm. Sci. 2006, 95 (7), 1448–1458.
(18) CAD-4 Software, version 5.0; Enraf-Nonius: Delft, The Netherlands,
1989.
(19) Sheldrick, G. M. SHELXL97 and SHELXS97; University of Go¨ttingen:
Go¨ttingen, Germany, 1997.
(20) Tkachenko, S. E.; Proshin, A. N.; Bachurin, S. O.; Petrova, L. N.;
Zefirov, N. S. Derivatives of N,S-Substituted N′-1-[(Hetero)arylalkyl]-
N′-[(hetero)aryl]-methylisothioureas, Method of Synthesis of Their
Bases and Salts, Physiologically Active N′-1-[(hetero)arylalkyl]-N′-
[(hetero)aryl]-methylisothioureas, Pharmaceutical Formulation and
Method of Treatment. Russian Patent 2223952, February 20, 2004
(according to the Patent Application 2001114922 of June 4, 2001).
KI ) K(43/21) ) [(Ca4 - Ca3)/(Ca2 - Ca1)] × 100
(3)
where Ca1 is the Ca2+ influx in blank experiment (without glutamate
and tested compounds). Ca2 is the Ca2+ influx in the presence of
glutamate only (Glu-Ca-uptake), Ca3 is the Ca2+ influx in the
presence of tested compound (without glutamate), and Ca4 is the
Ca2+ influx in the presence of both glutamate and tested compound.
Electrophysiological Experiments. The AMPA-ligands activity
studies were carried out on isolated Purkinje neurons that contain
a broad population of AMPA-receptors. The main series of
experiments were performed with kainic acid (KA) as receptor
agonist because glutamate and especially AMPA induce fast and
strong desensitization of receptors, which makes the study of
dose-response relationships very difficult. Electrophysiological
experiments were carried out on freshly isolated neurons from
different areas of the brain of 14-18 days old rats using the patch-
clamp technique. The preparation of isolated cells was performed
as follows: a selected region of the brain was cut into slices of
0.4-0.6 mm width followed by the incubation in saline (150 mM
NaCl, 5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 10 mM HEPES, 10
mM glucose, pH 7.4) for 1 h. The slices were transferred to fresh
saline solution with 2 mg/mL Pronase (Serva) and 1 mg/mL
collagenase (Sigma). Slices were incubated at 34 °C and pregassed
with 100% O2. Finally, the slices were mechanically dissociated
into individual cells by means of Pasteur pipettes. The composition
of extracellular saline was 150 mM NaCl, 5 mM KCl, 2.6 mM
CaCl2, 10 mM HEPES, 10 mM glucose, pH 7.32. The composition
of the intracellular saline was 140 mM KCl, 10 mM HEPES, 5
mM EGTA, 1 mM MgCl2, 1 mM ATP. The transmembrane currents
were registered in the configuration of “whole cell”. Compounds
were exposed to neurons by the method of fast perfusion.
JM8012882